7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer Treatment ...
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
The American Association for Cancer Research Annual Meeting 2025 will be held from April 25-30 in Chicago, Illinois, providing a ...
Ongoing proof-of-concept (PoC) clinical trial in pain associated with pancreatic cancer with topline data on track for 1H 2025Continued solid ...
Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...
Cedars-Sinai investigators are developing a tool using artificial intelligence to help predict pancreatic cancer in Black ...
News Medical on MSN3d
Pancreatic blood vessel cell map reveals potential diabetes treatment pathwaysThe distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...
Western genomes won’t cut it. Experts from IIT Madras and Karkinos Healthcare, leading the Bharat Cancer Genome Atlas (BCGA), ...
AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...
The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas have been notoriously ...
HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics for rare, common, chronic and age-associated diseases, announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback